Oncology is moving towards preventative, real-time, non-invasive treatment monitoring, early detection screenings, and targeted immunotherapies.
Personalized cancer vaccines represent a revolutionary shift in oncology. They analyze a patient’s unique tumor mutations to create custom therapies that train the immune system to hunt cancer cells while sparing healthy tissue. These treatments are showing profound clinical promise, reducing the risk of cancer recurrence by nearly 50% when paired with standard immunotherapies.
